78 related articles for article (PubMed ID: 21183897)
1. Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Berrutti M; Astegiano M; Smedile A; Fagoonee S; Rizzetto M; Pellicano R
Panminerva Med; 2010 Dec; 52(4):361-2. PubMed ID: 21183897
[No Abstract] [Full Text] [Related]
2. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
[No Abstract] [Full Text] [Related]
3. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Fagoonee S; Astegiano M; Smedile A; Pellicano R
Panminerva Med; 2013 Sep; 55(3):309-10. PubMed ID: 24088806
[No Abstract] [Full Text] [Related]
4. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
9. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
10. Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment.
Pellicano R; Fagoonee S; Astegiano M; Morgando A; Cisarò F; Rizzetto M
Minerva Med; 2011 Apr; 102(2):169-70. PubMed ID: 21483404
[No Abstract] [Full Text] [Related]
11. Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori?
Tokoro C; Inamori M; Koide T; Iida H; Sakamoto Y; Endo H; Hosono K; Takahashi H; Yoneda M; Yasuzaki H; Ogawa M; Abe Y; Kubota K; Saitou S; Kawana I; Matsuda R; Takahashi D; Nakajima A
Hepatogastroenterology; 2010; 57(104):1645-9. PubMed ID: 21443136
[TBL] [Abstract][Full Text] [Related]
12. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
13. [Differences between European guideline and planned S3 guideline of DGVS. Need for Helicobacter pylori eradication to be decided on an individual basis].
MMW Fortschr Med; 2008 Jun; 150(23):48-9. PubMed ID: 18578071
[No Abstract] [Full Text] [Related]
14. Efficacy of clarithromycin plus metronidazole-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Berrutti M; Fagoonee S; Strona S; Astegiano M; Morgando A; Rizzetto M; Pellicano R
Minerva Med; 2010 Dec; 101(6):457-8. PubMed ID: 21196905
[No Abstract] [Full Text] [Related]
15. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
Maconi G; Parente F; Russo A; Vago L; Imbesi V; Bianchi Porro G
Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
Qasim A; O'Morain CA; O'Connor HJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
[TBL] [Abstract][Full Text] [Related]
20. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Frem JC; Gold BD; Shehata BM; Cole CR
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
